Abstract
Interleukin-36 Blockade in Pustular Psoriasis Seven patients with pustular psoriasis, three with mutations in IL36RN, were treated with a monoclonal antibody against interleukin-36 receptor and had...
Cite
CITATION STYLE
APA
Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., … Thoma, C. (2019). Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis. New England Journal of Medicine, 380(10), 981–983. https://doi.org/10.1056/nejmc1811317
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free